Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting
Titel:
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting
Auteur:
Bettelli, Stefania Marcheselli, Raffaella Pozzi, Samantha Marcheselli, Luigi Papotti, Robel Forti, Elisa Cox, M. Christina Christina Di Napoli, Arianna Tadmor, Tamar Mansueto, Giovanna R. Musto, Pellegrino Flenghi, Leonardo Quintini, Martina Galimberti, Sara Lalinga, Vittoria Donati, Valentina Maiorana, Antonino Polliack, Aaron Sacchi, Stefano